DNM1P46: A Drug Target / Disease Biomarker (G196968)
DNM1P46: A Drug Target / Disease Biomarker
DNM1P46 is a protein that is expressed in various tissues of the body, including the brain, pancreas, and muscle. Its full name is dipeptidyl-nitrate-metal ion transporter 1 (DNM1), and it functions as a transporter for peptides that contain aromatic amino acids, such as tryptophan and tyrosine.
DNM1P46 is a key protein that is involved in the regulation of the levels of tryptophan and tyrosine in the body. Tryptophan is an essential amino acid that is involved in the synthesis of various neurotransmitters, including serotonin and norepinephrine. Tyrosine is a precursor to neurotransmitters, including dopamine, as well as to other molecules that play important roles in cellular signaling.
DNM1P46 is expressed in a variety of tissues and cells in the body, including the brain, pancreas, and muscle. It is highly expressed in the brain, where it is found in the postsynaptic density of neurons, and in the pancreas, where it is involved in the production of insulin. It is also expressed in other tissues, including muscle and red blood cells.
DNM1P46 is a protein that has been identified as a potential drug target or biomarker for a variety of psychiatric and neurological disorders. For example, it has been shown to be involved in the regulation of the levels of tryptophan and tyrosine in the brain, which could make it a useful target for treatments that target these neurotransmitters.
In addition, DNM1P46 has also been shown to be involved in the regulation of cellular signaling pathways that are important for a variety of cellular processes, including cell survival, migration, and angiogenesis. This suggests that it may be a useful target for treatments that target these processes.
Overall, DNM1P46 is a protein that is expressed in various tissues of the body and is involved in the regulation of the levels of tryptophan and tyrosine in the body. Its potential as a drug target or biomarker makes it an attractive target for research into a variety of psychiatric and neurological disorders.
Protein Name: Dynamin 1 Pseudogene 46
More Common Targets
DNM1P49 | DNM2 | DNM3 | DNM3OS | DNMBP | DNMBP-AS1 | DNMT1 | DNMT1-G9a-PCNA complex | DNMT1-HDAC2-DMAP1 complex | DNMT1-Rb-E2F1-HDAC1 complex | DNMT3A | DNMT3AP1 | DNMT3B | DNMT3L | DNPEP | DNPH1 | DNTT | DNTTIP1 | DNTTIP2 | DOC2A | DOC2B | DOC2GP | DOCK1 | DOCK10 | DOCK11 | DOCK2 | DOCK3 | DOCK4 | DOCK4-AS1 | DOCK5 | DOCK6 | DOCK7 | DOCK8 | DOCK8-AS1 | DOCK9 | DOCK9-DT | DOHH | DOK1 | DOK2 | DOK3 | DOK4 | DOK5 | DOK6 | DOK7 | Dolichol-phosphate-mannose synthase complex | DOLK | DOLPP1 | DONSON | DOP1A | DOP1B | Dopamine receptor | DOT1L | Double homeobox protein 4 | DP2-E2F4 complex | DPAGT1 | DPCD | DPEP1 | DPEP2 | DPEP3 | DPF1 | DPF2 | DPF3 | DPH1 | DPH2 | DPH3 | DPH3P1 | DPH5 | DPH5-DT | DPH6 | DPH6-DT | DPH7 | DPM1 | DPM2 | DPM3 | DPP10 | DPP10-AS1 | DPP3 | DPP3-DT | DPP4 | DPP6 | DPP7 | DPP8 | DPP9 | DPP9-AS1 | DPPA2 | DPPA2P3 | DPPA3 | DPPA3P1 | DPPA3P2 | DPPA4 | DPPA4P3 | DPPA5 | DPPA5P4 | DPRX | DPRXP2 | DPRXP4 | DPT | DPY19L1 | DPY19L1P1 | DPY19L2